Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy vs Radiotherapy Alone in Localised Muscle Invasive Bladder Cancer
NCT00330499Phase 3Completed
- Sponsor
- Trans-Tasman Radiation Oncology Group
- Start
- Oct 2002
- Primary completion
- Feb 2010
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in transitional cell carcinoma of the urinary bladder (TCC), sponsored by Trans-Tasman Radiation Oncology Group. Started Oct 2002; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
transitional cell carcinoma of the urinary bladder (TCC)
Beyond the preview
Go deeper on NCT00330499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330499.